Lupin launches Clobazam Tablets
(10 May 2019)
Pharma major Lupin announced the launch of Clobazam Tablets,
10 mg and 20 mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin's Clobazam Tablets, 10 mg and 20 mg is the generic version of Lundbeck Pharms, LLts Onfi® Tablets, 10 mg and 20 mg. It is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.